Search

Search Constraints

You searched for: Author/Creator Clark, Richard E.

Search Results

1. A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial. (6th April 2022)

2. A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial. (7th May 2021)

3. A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands. (17th May 2022)

5. Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5′ AMP-activated protein kinase signalling in malignant cells. Issue 15 (15th August 2019)

6. Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses. Issue 8 (10th March 2021)

7. Evaluating the use of plerixafor in stem cell mobilisation – an economic analysis of the PHANTASTIC trial. Issue 5 (29th September 2015)

10. Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. Issue 11 (14th September 2019)